Triomics

Generative AI for Oncology EHRs

Winter 2021

Active

Generative AI for Oncology EHRs

Triomics is helping cancer care providers by reducing the burden associated with manually reviewing patient charts. Utilizing our OncoLLM™—a family of oncology-focused language models—we are able to accelerate clinical trial enrollment, power quality improvement projects, and address many other key strategic priorities.

Active Founders

Sarim Khan

Sarim Khan, Founder

I am a chemical engineer with previous research experience in tissue engineering and neuroscience. The lack of vertical integration in the clinical trial space inspired me to work on Triomics.

Sajjan Rajpurohit

Sajjan Rajpurohit, Founder

I am a Medical Oncologist with over 12 years of experience.

Hrituraj Singh

Hrituraj Singh, Founder

Before starting Triomics, I was a Researcher at Adobe Research, where I worked on language models and reinforcement learning problems. I now use the same technologies to interpret oncology patient charts.

Latest News

Triomics raises $15M Series A to automate cancer clinical trials matching | TechCrunch

May 09, 2024

Jobs at Triomics

View all jobs

Strategy & Operations Associate

New York, NY, US

$100K - $120K

1+ years

Apply Now ›

Lead Research Scientist, NLP

San Francisco, CA, US / Remote (US)